Abstract

Postprandial blood glucose excursions are important for achieving optimal glycemic control. In normal-weight individuals, glucose tolerance is diminished in the evening compared to glucose tolerance in the morning. Wheat albumin (WA) has the potential to suppress the postprandial glucose response with a relatively small dose, compared to the dose required when using dietary fiber. In the present study, the effect of WA on glycemic control during the night was investigated after a late evening meal. A randomly assigned crossover trial involving a single oral ingestion in healthy male participants was performed in a double-blind placebo-controlled manner. The participants ingested the placebo (PL) tablets or the WA (1.5 g)-containing tablets 3 min before an evening meal at 22:00 hour, and blood samples were drawn during the night until 07:00 hour using an intravenous cannula. The participants slept from 00:30 hour to 06:30 hour. Glucose response, as a primary outcome during the night, was suppressed significantly by the WA treatment compared to the PL treatment, but the insulin response was not. Plasma glucose-dependent insulinotropic polypeptide concentration during the night was lowered significantly by the WA treatment compared to the PL treatment. In conclusion, WA may be a useful food constituent for glycemic control during the night.

Highlights

  • An estimated 425 million people worldwide had diabetes in 2017, and this number is projected to reach 700 million by 2045 [1]

  • There has been a strong emphasis on fasting plasma glucose, and the predominant focus of therapy has been on lowering hemoglobin A1c (HbA1c) levels [5]

  • The use of a variety of both non-pharmacologic and pharmacologic therapies is recommended to control postprandial plasma glucose [7]. This is relevant during the night, as glucose tolerance is diminished compared to its level in the morning, even in normal-weight individuals [8,9,10,11,12,13,14,15,16]

Read more

Summary

Introduction

An estimated 425 million people worldwide had diabetes in 2017, and this number is projected to reach 700 million by 2045 [1]. The use of a variety of both non-pharmacologic and pharmacologic therapies is recommended to control postprandial plasma glucose [7]. This is relevant during the night, as glucose tolerance is diminished compared to its level in the morning, even in normal-weight individuals [8,9,10,11,12,13,14,15,16]. Even in healthy, non-diabetic people, the use of non-pharmacologic therapies, such as the control of dietary and fitness habits, to protect against impaired glucose tolerance during the night is recommended

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.